CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

Phase 3CadonilimabNivolumabcadonilimab
Related Companies

Read the original article

Published by PR Newswire Biotech on September 28, 2026 2:05 AM

Read Original